Recap: Biotech's Finest Hour

Search General Info
Search Education
Search Partnering Companies

Recap: Biotech's Finest Hour

The COVID-19 pandemic has changed the world in fundamental ways, and the biotechnology sector has been summoned to marshal its broad arsenal of next-generation weapons to beat this disease. As the world undergoes a change, so, too, does BIO.

BIO Chairman Jeremy Levin, Former President & CEO Jim Greenwood, and BIO's new President and CEO Michelle McMurry-Heath kicked off BIO Digital week with an engaging session on how the biotech sector is rising to meet the greatest public health challenge in a century.

Here are some highlights from their session:

Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour
Biotech's Finest Hour